Loading the company…
Loading the company…
㈜엘티팜
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Chungbuk, founded in 2012. Industry: R&D & Professional Services. Revenue for 2025 was ₩7.4bn. It has 41 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2025-09-12 · newest first
일 양상은 글라브리딘(Glabridin)을 포함하는 탈모증의 예방 또는 개선 및 발모 촉진용 화장료 조성물에 관한 것이다. 일 양상에 따른 화장료 조성물은 글라브리딘을 포함함으로써, 상처 치유 효과, 알칼리성 인산화효소 활성 증진 효과, 세포 내 활성산소 억제 효과 및 미토콘드리아의 막 전위 회복효과가 우수한 바, 두피 상태 개선 및 발모 촉진 효과가 우수하며, 이로 인한 탈모 예방 또는 치료 효과까지 기대할 수 있다. 따라서, 상기 글라브리딘을 포함하는 화장료 조성물은 탈모증의 예방 또는 개선 및 발모 촉진용 피부 외용제 및 건강기능식품 뿐만 아니라, 탈모증 예방 또는 치료를 위한 약학적 조성물까지 다양한 산업분야에서 활용될 수 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 7.7 | 7.4 |
| Cost of sales | 5.2 | 4.9 |
| Gross profit (loss) | 2.4 | 2.5 |
| Selling, general and administrative expenses | 1.5 | 1.4 |
| Operating income (loss) | 1.0 | 1.1 |
| Non-operating income | 0.0 | 0.0 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | — | 0.0 |
| Non-operating expenses | 1.0 | 0.9 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.9 | 0.9 |
| Other | 0.0 | 0.0 |
| Profit (loss) before tax | 0.0 | 0.2 |
| Income tax expense | 0.0 | 0.0 |
| Net income (loss) | 0.0 | 0.2 |
Revenue ₩7.4bn, down 3.2% YoY.
Operating margin 14.8% (prior 12.5%).
Net income ₩0.2bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.